Anti-PEG Antibodies

Detect PEGylated molecules with monoclonal anti-PEG antibodies — validated for ELISA, WB, and immunoassay. Essential for PEGylated drug PK studies. RUO

Por qué los investigadores eligen abinScience

Reactivos altamente especializados Purpose-built antibodies for niche research applications with validated performance data on every datasheet.

Validación rigurosa de aplicaciones Each antibody tested in relevant applications with supporting images and quantitative data.

Fabricante original Developed and produced in-house — full traceability, batch consistency, and competitive pricing.

Soporte técnico experto Application scientists available for reagent selection, protocol optimization, and troubleshooting.

Opciones flexibles Unconjugated and conjugated formats; bulk quantities and custom conjugation available on request.

Documentos & datos de QC

Download product datasheets, imágenes de validación (WB/IHC/IF/FC), CoA, and application protocols on each product page. All data is lot-specific.

Preguntas frecuentes

¿Cómo se validan sus anticuerpos?

Every antibody is validated in its listed applications (WB, IHC, IF, ELISA, FC) with supporting images and data on the product page. We use positive and negative controls plus knockout/knockdown verification where available.

¿Ofrecen anticuerpos conjugados?

Yes — HRP, AP, biotin, FITC, PE, APC, Alexa Fluor, and other fluorochrome conjugates are available. Custom conjugation services are also offered for bulk orders.

¿Con qué especies reaccionan sus anticuerpos?

Most antibodies target human, mouse, and rat. Many show validated cross-reactivity with additional species. Check the product datasheet for confirmed reactivity data.

¿Cuál es su política de reemplazo?

If a product does not perform as described under recommended conditions, contact us within 30 days for replacement or credit. Our technical team will help troubleshoot first.

¿Puedo obtener anticuerpos personalizados?

Yes — our parent company AtaGenix offers full custom antibody development from immunogen design through hybridoma screening and scale-up production.